◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
D.Western Therapeutics Institute, Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 471.6M 428.4M 448.1M 414.4M 355.6M
Revenue Growth % 10.1% -4.4% 8.1% 16.5% --
+Operating Income -1.2B -798.6M -305.9M -171.6M -265.7M
Operating Margin % -256.5% -186.4% -68.3% -41.4% -74.7%
Non Operating Income 2.1M 6.7M 38.5M 17.8M 2.6M
Non Operating Expenses 20.6M 4.5M 28.4M 5.9M 26.5M
Ordinary Income -1.2B -796.4M -295.8M -159.7M -289.5M
Income Before Taxes -1.3B -826.8M -440.3M -159.7M -289.5M
Income Taxes 1.6M 1.6M 1.6M 1.6M 1.6M
+Net Income -1.3B -812.4M -429.7M -149.0M -276.1M
Net Margin % -273.6% -189.7% -95.9% -36.0% -77.6%
Eps -36.74 -25.56 -14.50 -5.08 -10.16
Depreciation Amortization 49.3M 48.7M 46.4M 45.3M 44.2M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Deposits 1.1B 1.9B 2.3B 1.9B 2.3B
Current Assets 1.5B 2.1B 2.7B 2.2B 2.5B
Property Plant Equipment 11.2M 10.0M 10.1M 4.6M 5.3M
Noncurrent Assets 194.1M 235.4M 297.3M 300.7M 234.4M
Total Assets 1.7B 2.4B 3.0B 2.5B 2.7B
Current Liabilities 132.6M 194.0M 211.2M 193.2M 209.8M
Total Liabilities 935.6M 1.1B 1.1B 427.7M 573.8M
Retained Earnings -3.7B -2.4B -1.6B -1.2B -1.1B
Total Equity 733.9M 1.3B 1.9B 2.0B 2.2B
Equity Ratio 0.44 0.54 0.63 0.81 0.79
Book Value Per Share 17.59 39.81 60.14 68.27 73.88
Num Employees 21.00 21.00 20.00 19.00 15.00
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Operating Cash Flow -1.3B -586.8M -354.8M -176.3M -216.3M
Investing Cash Flow -10.0M -15.3M -139.9M -111.2M -13.5M
Financing Cash Flow 567.6M 134.5M 867.3M -104.5M 1.0B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...